Samsara BioCapital reported a 9.9% stake in Rani Therapeutics Holdings RANI · 11,322,961 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 9.9%
Last report: 9.9% · filed 25/10/30
Shares held: 11,322,961 sh
Class: Class A Common Stock, $0.0001 par value per share
Stock: Rani Therapeutics Holdings RANI
Holder: Samsara BioCapital
Event date: 26/05/26
Filed: 26/05/28

9.9% stake · +0.0pp from the last report

Stake: 9.9%
Last report: 9.9%
Since last report: +0.0pp

Rani Therapeutics Holdings trades, last 26 weeks

What else happened in Rani Therapeutics Holdings around then

Filed or reported within 30 days of the trade day · 04/26~06/25

Samsara BioCapital's other 5% stake reports

Samsara BioCapital
5% stakePMV Pharmaceuticals
5% stake
PMV Pharmaceuticals
PMVP
9.9% stake
7,577,467 sh
9.9% stake
Filed 09/15
Samsara BioCapital
5% stakeEloxx Pharmaceuticals
5% stake
Eloxx Pharmaceuticals
ELOX
9.9% stake
403,586 sh
9.9% stake
Filed 08/14
Samsara BioCapital
5% stakeKalaris Therapeutics
5% stake
Kalaris Therapeutics
KLRS
54.2% stake
12,900,583 sh
54.2% stake
Filed 05/22
Samsara BioCapital
5% stakeSutro Biopharma
5% stake
Sutro Biopharma
STRO
6.4% stake
1,062,872 sh
6.4% stake
Filed 05/15
Samsara BioCapital
5% stakeKalaris Therapeutics
5% stake
Kalaris Therapeutics
KLRS
56.5% stake
12,954,081 sh
56.5% stake
Filed 02/17